Financial news: CompuMed sees mixed results
CompuMed (CMPD.OB) a medical informatics company leading the development of advanced imaging technology for cost effective analysis and monitoring, reported fiscal 2006 total revenues of $2.11 million, compared to $2.28 million in fiscal 2005. Net loss was $424,000, compared to a loss of $336,000, or $0.02 per share, for the prior fiscal year. However, revenues from CompuMed's OsteoGram osteoporosis diagnostics increased 125 percent to $265,000, compared to $118,000, as a result of higher sales to OEM licensing partners. Revenues from CompuMed's core electrocardiogram (ECG) products, supplies and services decreased 3 percent to $1.67 million, from $1.73 million. ECG equipment and supply sales decreased 59 percent during fiscal 2006 to $180,000, compared to $440,000 during the prior fiscal year.